Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stanford trial studies vastly shorter radiation time for breast cancer treatment

21.11.2002


A new radiation approach being tested at Stanford University Medical Center could shorten the overall treatment time for women with breast cancer. Participants will receive a single dose of radiation at the time of surgery rather than the usual six-week course of radiation therapy. The clinical trial is now recruiting patients.



"The trial should tell us whether this accelerated form of radiotherapy is safe, feasible and effective in controlling cancer recurrence in the breast for certain women who have a lumpectomy," said Frederick Dirbas, MD, assistant professor of surgical oncology at the Stanford School of Medicine and leader of the trial.

Women with a breast tumor often have a lumpectomy, surgery in which the doctor removes only the cancerous region, leaving the rest of the breast intact. The patient then receives a dose of radiation to the entire breast each weekday for about the next six weeks to minimize the risk of cancer returning.


"The fact that current radiation treatments occur every day for several weeks makes it an issue for women," Dirbas said, adding that the schedule can be inconvenient for women who work, care for young children or live far from the treatment site. He said the idea behind this prolonged schedule was that women would experience fewer side effects if the total radiation dose was broken into smaller increments.

In recent years, however, doctors in the United States and Europe have begun looking at approaches to shorten the overall treatment time while still fending off cancer. In one Italian trial with more than 100 participants, patients received a single large dose of radiation at the same time as the surgery. Two years after the initial surgery, the treatment appears to be safe and effective.

Based on this success, Dirbas and Donald Goffinet, MD, professor of radiation oncology, are replicating the Italian trial - the first U.S. trial of this technique. They hope to recruit 50 women who are older than 40, have a single breast tumor that is smaller than 2.5 centimeters and have a low likelihood of tumors elsewhere in the breast.

For information about participating in the trial, please call Janelle Maxwell at 650-498-7740.


Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children’s Hospital at Stanford. For more information, please visit the Web site of the medical center’s Office of Communication & Public Affairs at http://mednews.stanford.edu.

Neale Mulligan | EurekAlert!
Further information:
http://med-www.stanford.edu/MedCenter/MedSchool/
http://mednews.stanford.edu

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>